Valuation: NetraMark Holdings Inc.

Market Cap 6.15Cr 4.45Cr 3.82Cr 3.55Cr 3.28Cr 426.49Cr 6.26Cr 42Cr 16Cr 213.76Cr 17Cr 16Cr 704.85Cr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 6.15Cr 4.45Cr 3.82Cr 3.55Cr 3.28Cr 426.49Cr 6.26Cr 42Cr 16Cr 213.76Cr 17Cr 16Cr 704.85Cr EV / Sales 2026 *
153x
EV / Sales 2027 * -
Free-Float
91.14%
Yield 2026 *
-
Yield 2027 * -
1 week-7.14%
Current month-18.75%
1 month-18.75%
3 months-26.97%
6 months-38.10%
Current year-40.91%
1 week 0.62
Extreme 0.62
0.75
1 month 0.62
Extreme 0.62
0.85
Current year 0.59
Extreme 0.59
1.28
1 year 0.59
Extreme 0.59
1.8
3 years 0.16
Extreme 0.155
1.8
5 years 0.15
Extreme 0.15
1.97
10 years 0.15
Extreme 0.15
3.17
Manager TitleAgeSince
Chief Executive Officer - 17/02/2022
President - 04/07/2022
Director of Finance/CFO 57 18/07/2022
Director TitleAgeSince
Chairman 40 09/06/2025
Director/Board Member - -
Director/Board Member - 16/06/2022
Date Insider Type Main position Quantity % Market Cap.
13/04/26 Tax

Chairperson

4,34,178 0.4686%
19/02/26 Option

Executive/Senior Manager

1,16,250 0.1354%
19/02/26 Other

Executive/Senior Manager

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-7.14%-60.84%+170.83% 4.43Cr
+0.56%-3.87%-6.34%+53.03% 3,57600Cr
+2.13%+0.14%+0.67%+1,116.60% 41TCr
-0.49%-3.83%-11.58%+42.82% 8.72TCr
-5.07%-5.37%+80.93%+149.41% 8.83TCr
-0.78%-2.35%-35.84%-5.82% 7.74TCr
+2.44%-9.44%-32.81%+207.91% 7.12TCr
-2.21%-5.37%+1.93%+72.44% 4.53TCr
+6.89%+13.08%+2.99%-6.48% 4.13TCr
-4.41%-13.32%+111.20%+274.09% 3.56TCr
Average +0.37%-3.71%+5.03%+207.48% 44.35TCr
Weighted average by Cap. +0.05%-4.07%-3.88%+156.49%

Financials

2026 *2027 *
Net sales 4L 3L 2L 2L 2L 2.78Cr 4L 27.38L 10.71L 1.39Cr 10.9L 10.66L 4.59Cr -
Net income - -
Net Debt - -
Logo NetraMark Holdings Inc.
NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.
Employees
-
Date Price Change Volume
19/26/19 CA$0.6500 0.00% 32,652
18/26/18 CA$0.6500 -5.80% 41,402
17/26/17 CA$0.6900 +1.47% 1,15,000
14/26/14 CA$0.6800 +3.03% 11,638
13/26/13 CA$0.6600 -1.49% 26,500

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AIAI Stock